Clinical features and genetic characteristics of two Chinese pedigrees with fatal family insomnia

References

• Lugaresi E, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med. 1986;315(16):997–1003.
   PubMed Web of Science ®Google Scholar
• Capellari S, Strammiello R, Saverioni D, et al. Genetic Creutzfeldt–jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol. 2011;121(1):21–37.
   PubMed Web of Science ®Google Scholar
• Parchi P, Capellari S, Gambetti P. Fatal familial and sporadic insomnia. Oxford: Wiley‐Blackwell; 2011. p. 346–349.
   Google Scholar
• Rupprecht S, Grimm A, Schultze T, et al. Does the clinical phenotype of fatal familial insomnia depend on PRNP codon 129 methionine-valine polymorphism? J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2013;9(12):1343–1345.
   PubMed Web of Science ®Google Scholar
• Gistau VS, Pintor L, Matrai S, et al. Fatal familial insomnia. Psychosomatics. 2006;47(6):527–528.
   PubMed Web of Science ®Google Scholar
• Wu L, Lu H, Wang X, et al. Clinical features and sleep analysis of Chinese patients with fatal familial insomnia. Sci Rep. 2017;7(1):3625.
   PubMedGoogle Scholar
• Manetto V, Medori R, Cortelli P, et al. Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology. 1992;42(2):312–319.
   PubMed Web of Science ®Google Scholar
• Gao C. Clinical and familial characteristics of ten chinese patients with fatal family insomnia. Biomedical Environ Sci. 2012;25(4):471–475.
   PubMed Web of Science ®Google Scholar
• Cao C, Dong XP. Epidemiological characteristics of human prion diseases. Infect Dis Poverty. 2016;5(1):1–10.
   PubMedGoogle Scholar
• Brown K, Mastrianni JA. The prion diseases. J Geriatric Psychiatry Neurol. 2010;23(4):277.
   PubMed Web of Science ®Google Scholar
• Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992;258(5083):806–808.
   PubMed Web of Science ®Google Scholar
• Xavier R, Malcolm G, Leblanc AC. Neuroprotective functions of prion protein. J Neurosci Res. 2010;75(2):153–161.
   Google Scholar
• Bagyinszky E, Giau VV, Youn YC, et al. Characterization of mutations in (prion) gene and their possible roles in neurodegenerative diseases. Neuropsychiatr Dis Treat. 2018;14:2067–2085.
   PubMed Web of Science ®Google Scholar
• Shi Q, Zhou W, Chen C, et al. The features of genetic prion diseases based on Chinese surveillance program. Plos One. 2015;10(10):e0139552.
   PubMed Web of Science ®Google Scholar
• Sun C, Xia W, Liu Y, et al. Agrypnia excitata and obstructive apnea in a patient with fatal familial insomnia from China: A case report. Medicine (Baltimore). 2017;96(49):e8951.
   PubMed Web of Science ®Google Scholar
• Sun L, Li X, Lin X, et al. Familial fatal insomnia with atypical clinical features in a patient with D178N mutation and homozygosity for Met at codon 129 of the prion protein gene. Prion. 2015;9(3):228–235.
   PubMed Web of Science ®Google Scholar
• Macchi G, Rossi G, Abbamondi AL, et al. Diffuse thalamic degeneration in fatal familial insomnia. A morphometric study. Brain Res. 1997;771(1):154–158.
   PubMed Web of Science ®Google Scholar
• Tinuper P, Montagna P, Medori R, et al. The thalamus participates in the regulation of the sleep-waking cycle. A clinico-pathological study in fatal familial thalamic degeneration. Electroencephalography Clin Neurophysiol. 1989;73(2):117–123.
   PubMedGoogle Scholar
• Tham WY, Thian YL, Ratnagopal P, et al. 18F-FDG PET brain in a patient with fatal familial insomnia. Clin Nucl Med. 2018;43(8):e274–e275.
   PubMed Web of Science ®Google Scholar
• Pperani C. Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and ~(18)FDG-PET studies. Dig World Core Med J. 2006;129(3):668–675.
   Google Scholar
• Llorens F, Zarranz J, Fischer A, et al. Fatal familial insomnia: clinical aspects and molecular alterations. Curr Neurol Neurosci Rep. 2017;17(4):30.
   PubMed Web of Science ®Google Scholar
• Huang X, Pu W, Li X, et al. Decreased left putamen and thalamus volume correlates with delusions in first-episode schizophrenia patients. Front Psychiatry. 2017;8:245.
   PubMed Web of Science ®Google Scholar
• Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 2010;9(5):493–507.
   Google Scholar
• Ozawa T, Shinoda H, Tomita M, et al. Pathogenesis of laryngeal narrowing in patients with multiple system atrophy. J Physiol. 2001;536:237–249.
   PubMed Web of Science ®Google Scholar
• Mrkobrada S, Wei XC, Gnanakumar V. Magnetic resonance imaging findings of bilateral thalamic involvement in severe paroxysmal sympathetic hyperactivity: a pediatric case series. Child’s Nerv Syst. 2016;32(7):1299–1303.
   PubMed Web of Science ®Google Scholar
• Qiu MH. Basal ganglia control of sleep-wake behavior and cortical activation. Eur J Neurosci. 2010;31(3):499–507.
   PubMed Web of Science ®Google Scholar
• Wu LY, Zhan SQ, Huang ZY, et al. Expert consensus on clinical diagnostic criteria for fatal familial insomnia. Chin Med J (Engl). 2018;131(13):1613.
   PubMed Web of Science ®Google Scholar
• Sun Q, Xie N, Tang B, et al. Alzheimer’s disease: from genetic variants to the distinct pathological mechanisms. Front Mol Neurosci. 2017;10:319.
   PubMed Web of Science ®Google Scholar
• He R, Yan X, Guo J, et al. Recent advances in biomarkers for Parkinson’s disease. Front Aging Neurosci. 2018;10:305.
   PubMed Web of Science ®Google Scholar
• Sanxi A, Lu S, Jifeng G, et al. DNA methylation as a biomarker for neuropsychiatric diseases. Int J Neurosci. 2012;122(4):165–176.
   PubMed Web of Science ®Google Scholar
• Bin P, Shenqi Z, Hongjuan D, et al. Clinical, histopathological and genetic studies in a case of fatal familial insomnia with review of the literature. Int J Clin Exp Pathol. 2015;8(9):10171.
   PubMed Web of Science ®Google Scholar
• Tabaee Damavandi P, Dove MT, Pickersgill RW. A review of drug therapy for sporadic fatal insomnia. Prion. 2017;11(5):293–299.
   PubMed Web of Science ®Google Scholar
• Wang X, Li P, Pan C, et al. The effect of mind-body therapies on insomnia: a systematic review and meta-analysis. Evidence-based complementary and alternative medicine: eCAM. 2019;2019:9359807.
   Google Scholar